The United Laboratories International Holdings Limited (3933.HK)
Manufactures and sells antibiotics, insulin, vitamins, and veterinary medicines globally.
9.19+0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-36.9%
The outlook
The stock trades near its 52-week low with strong analyst backing—the consensus averages a "Strong Buy" rating, and the average price target sits about 67% above the current price. Price momentum is mixed relative to moving averages, and the valuation appears compressed at a trailing P/E of 7.2. Overall sentiment leans cautiously optimistic, though the stock has yet to show clear upward momentum.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 9 analysts
Price trendMixed vs its moving averages
52-week range12% of the way from its 52-week low to high
Price targetAvg target +67% vs current price
Analyst price target
~12-month · 9 analysts15.35average target+67.1% vs now
Now 9.19
Low 12.80High 20.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$18.11B
52-wk high
17.98
52-wk low
7.98
50-day avg
8.85
200-day avg
10.99
Trailing P/E
7.2